DGAM
MRNA icon

Desjardins Global Asset Management’s Moderna MRNA Stock Holding History

Desjardins Global Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$151K Buy
1,520
+22
+1% +$1.85K 0.02% 398
2023
Q3 		$155K Sell
1,498
-264
-15% -$29.4K 0.02% 415
2023
Q2 		$214K Buy
1,762
+260
+17% +$34.7K 0.02% 420
2023
Q1 		$231K Buy
+1,502
New +$248K 0.03% 389

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Desjardins Global Asset Management's MRNA Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Moderna (MRNA) stake by 1.5% in Q4 2023, buying an estimated $1.85K and bringing the position to 1,520 shares worth $151K. The position accounts for 0.02% of the portfolio, ranked #398.

Desjardins Global Asset Management first reported a position in MRNA in Q1 2023 and has held it in 4 quarters since. The position peaked at $231K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Desjardins Global Asset Management held 1,520 shares of Moderna worth $151K as of Q4 2023.
  • Desjardins Global Asset Management bought 22 Moderna shares in Q4 2023, an estimated $1.85K.
  • Moderna made up 0.02% of Desjardins Global Asset Management's portfolio in Q4 2023, its #398 holding.
  • Desjardins Global Asset Management first reported a position in Moderna in Q1 2023 and has held it in 4 quarters since.
  • Desjardins Global Asset Management's Moderna position peaked at $231K in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.